Original Article

Relative Efficacy of 225Ac-PSMA-617 and 177Lu-PSMA-617 in Prostate Cancer Based on Subcellular Dosimetry
  • Hwan Lee
Mol Imaging Radionucl Ther 2022; 31: 1-6 DOI: 10.4274/mirt.galenos.2021.63308 PMID:35114745
Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry
  • Levent Kabasakal
  • Türkay Toklu
  • Nami Yeyin
  • Emre Demirci
  • Mohammad Abuqbeitah
  • Meltem Ocak
  • Aslan Aygün
  • Emre Karayel
  • Hüseyin Pehlivanoglu
  • Nalan Alan Selçuk
Mol Imaging Radionucl Ther 2017; 26: 62-68 DOI: 10.4274/mirt.08760 PMID:28613198

Interesting Image

Metastatic Superscan in 18F PSMA PET/CT of a Patient with Prostate Carcinoma
  • Man Mohan Singh
  • Shashwat Verma
  • Lavish Kakkar
  • Satyawati Deswal
  • Priyamedha Bose Thakur
Mol Imaging Radionucl Ther 2024; 33: 38-39 DOI: 10.4274/mirt.galenos.2023.68815 PMID:38390777
68Ga Prostate-specific Membrane Antigen Uptake in Metastatic Medullary Thyroid Carcinoma
  • Kübra Şahin
  • Ali Kibar
  • Cansu Güneren
  • Muhammet Sait Sağer
  • Kerim Sönmezoğlu
Mol Imaging Radionucl Ther 2024; 33: 54-56 DOI: 10.4274/mirt.galenos.2023.47855 PMID:38390812